Case Study
⭐ 4.7
Cost–Benefit Analysis in Pharmacovigilance for Insurance Underwriters: Post-Pandemic Lessons
Abstract
This case study investigates “Cost–Benefit Analysis in Pharmacovigilance for Insurance Underwriters: Post-Pandemic Lessons” using a Delphi study. Through a human-centered lens, the analysis integrates multi-source data to derive novel empirical evidence for researchers and practitioners.